I ran across one timeline for clinical trial approval in Brazil on a COVID-19 treatment.
It took one month between releasing the data from Sorrento's COVI-MSC phase 1b trial and a phase 2 trial approval in Brazil. That seems pretty fast.
(8)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-